CIK 0000275053 · Accelerated filer<br>Smaller reporting company
NATURES SUNSHINE PRODUCTS INC
Sign in to watch- Ticker
- NATR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- UT
- Entity type
- operating
- EIN
- 870327982
- Phone
- (801) 341-7900
- Business address
- 2901 WEST BLUEGRASS BLVD., SUITE 100, LEHI, UT, 84048
- Open-market buys, last 90 days
- $3,143,611
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$3,143,611. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-06 | Straus Robert D Director | Grant or award | +8,075 | 18,694 | ||
| 2020-05-06 | Watkins Jeffrey D Director | Grant or award | +8,075 | 44,915 | ||
| 2020-05-06 | MOSS RICHARD D Director | Grant or award | +8,075 | 13,289 | ||
| 2020-05-05 | BATY JOSEPH W EVP & Chief Financial Officer | Option exercise | +2,500 | 88,534 | ||
| 2020-05-05 | BATY JOSEPH W EVP & Chief Financial Officer | Shares withheld for taxes | −609 | $8.14 | $5K | 87,925 |
| 2020-04-01 | Moorehead Terrence CEO | Grant or award | +64,128 | $7.83 | $502K | 215,904 |
| 2020-04-01 | Moorehead Terrence CEO | Grant or award · Performance Units | +111,832 | 111,832 | ||
| 2020-04-01 | Moorehead Terrence CEO | Grant or award · Performance Units | +59,451 | 114,155 | ||
| 2020-03-30 | BATY JOSEPH W EVP & Chief Financial Officer | Grant or award | +29,310 | $7.83 | $229K | 86,034 |
| 2020-03-30 | BATY JOSEPH W EVP & Chief Financial Officer | Grant or award · Performance Units | +51,114 | 51,114 | ||
| 2020-03-27 | Moorehead Terrence CEO | Shares withheld for taxes | −4,458 | $7.83 | $35K | 151,776 |
| 2020-02-12 | BATY JOSEPH W EVP & Chief Financial Officer | Shares withheld for taxes | −812 | $10.55 | $9K | 56,724 |
| 2020-01-02 | BATY JOSEPH W EVP & Chief Financial Officer | Shares withheld for taxes | −1,318 | $9.04 | $12K | 57,536 |
| 2020-01-01 | BATY JOSEPH W EVP & Chief Financial Officer | Shares withheld for taxes | −1,730 | $9.04 | $16K | 58,854 |
| 2019-12-11 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% owner | Other acquisition | +14,125 | 14,125 | ||
| 2019-12-11 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% owner | Other acquisition | +25,000 | $7.80 | $195K | 39,125 |
| 2019-12-09 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP 10% owner | Purchase | +1,048 | $9.74 | $10K | 746,891 |
| 2019-12-09 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP 10% owner | Purchase | +2,288 | $9.74 | $22K | 1,641,540 |
| 2019-12-06 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP 10% owner | Purchase | +64 | $9.77 | $625 | 745,843 |
| 2019-12-06 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP 10% owner | Purchase | +140 | $9.77 | $1K | 1,639,252 |
Page 32 of 92 · 1,829 trades